These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18980750)

  • 21. Heart failure post-myocardial infarction: a review of the issues.
    Dargie H
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii3-6; discussion ii31, ii43-8. PubMed ID: 15831607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is viability still viable after the STICH trial?
    Cortigiani L; Bigi R; Sicari R
    Eur Heart J Cardiovasc Imaging; 2012 Mar; 13(3):219-26. PubMed ID: 22080451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial hibernation: a noninvasive physician's point of view.
    Bonow RO
    Ital Heart J; 2002 May; 3(5):285-90. PubMed ID: 12066559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial hibernation: a clinician's perspective.
    Beller GA
    Ital Heart J; 2002 May; 3(5):291-3. PubMed ID: 12066560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of myocardial viability in patients before revascularization].
    Jiménez Borreguero LJ; Ruiz-Salmerón R
    Rev Esp Cardiol; 2003 Jul; 56(7):721-33. PubMed ID: 12855155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of myocardial viability in chronic ischemic heart disease: current status.
    Rizzello V; Poldermans D; Bax JJ
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial viability: magnetic resonance assessment of functional reserve and tissue characterization.
    Watzinger N; Saeed M; Wendland MF; Akbari H; Lund G; Higgins CB
    J Cardiovasc Magn Reson; 2001; 3(3):195-208. PubMed ID: 11816616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET.
    Demirkol MO
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial viability in ischemic ventricular dysfunction.
    Gil VM
    Rev Port Cardiol; 1999 Sep; 18 Suppl 4():IV17-22. PubMed ID: 10555449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.
    Lee KS; Marwick TH; Cook SA; Go RT; Fix JS; James KB; Sapp SK; MacIntyre WJ; Thomas JD
    Circulation; 1994 Dec; 90(6):2687-94. PubMed ID: 7994809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shortening without contraction: new insights into hibernating myocardium.
    Nagel E; Schuster A
    JACC Cardiovasc Imaging; 2010 Jul; 3(7):731-3. PubMed ID: 20633851
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial SPECT in the study of ischemic heart disease detection of hibernating myocardium and evaluation of cost/benefit ratio.
    Giordano A; Calcagni ML; Verrillo A; Maccafeo S
    Rays; 1999; 24(1):73-80. PubMed ID: 10358385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible contractile dysfunction of viable myocardium. Implications for decision making process in post-infarction patients.
    Scognamiglio R; Fasoli G; Nistri S; Miorelli M; Palisi M; Marin M; Dalla-Volta S
    Herz; 1994 Aug; 19(4):221-6. PubMed ID: 7959536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is detection of hibernating myocardium necessary in deciding revascularization in systolic heart failure?
    Chatterjee K
    Am J Cardiol; 2010 Jul; 106(2):236-42. PubMed ID: 20599009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The basis of chronic ischemic reversible left ventricular dysfunction (hibernating myocardium)].
    Mates M; Veselka J
    Cesk Fysiol; 1999 Feb; 48(1):4-8. PubMed ID: 10377599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Postinfarction hibernating myocardium].
    Montalescot G; Faraggi M; Drobinski G; Le Guludec D; Grosgogeat Y; Thomas D
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1):79-84. PubMed ID: 7811155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical Implications of Myocardial Viability Studies.
    Ker WDS; Nunes THP; Nacif MS; Mesquita CT
    Arq Bras Cardiol; 2018 Mar; 110(3):278-288. PubMed ID: 29694555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of myocardial viability with cardiac magnetic resonance imaging.
    Grover S; Srinivasan G; Selvanayagam JB
    Prog Cardiovasc Dis; 2011; 54(3):204-14. PubMed ID: 22014488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reading tarot cards.
    Edmunds LH
    Surg Clin North Am; 2004 Feb; 84(1):323-31, xii-xiii. PubMed ID: 15053196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.